Shire Scorches FTC Suit Over Anti-Generic Petitions
Shire ViroPharma Inc. on Monday hammered a Federal Trade Commission antitrust suit over alleged abuse of the U.S. Food and Drug Administration's citizen petition process to delay generic competition, calling it...To view the full article, register now.
Already a subscriber? Click here to view full article